A second chance through research and care

“Without the research, transplants and procedures like mine wouldn’t exist.”

“Honestly, before all this, I thought research was more academic. But experiencing this firsthand, I’ve realized how important it is. It’s improved my quality of life significantly. Without the research, transplants and procedures like mine wouldn’t exist.”

“Research is critical. It’s what enables groundbreaking advancements. Fifty years from now, the challenges I faced will likely be much easier for others.”

In 2007, Ray Zhou was diagnosed with IgA nephropathy, a condition where his immune system mistakenly attacked his kidneys. Over time, his kidney function declined—from 100% to just 3% by early 2024. By then, dialysis was inevitable.

Ray’s journey took a turning point in 2015, when he was referred to Professor Natasha Rogers at Westmead Hospital. From that moment, she became his dedicated clinician, guiding him through the difficult years leading up to his transplant.

In March 2024, Ray was on the brink of a pre-dialysis transplant, but at the last moment, the opportunity fell through. He had to begin dialysis, continuing for six months before finally receiving a successful kidney transplant on September 17th.Now, three months post-surgery, he is off dialysis, regaining his strength, and getting back to exercise.

How Natasha Rogers’ research shaped Ray’s care

Ray’s care at Westmead Hospital was directly informed by the cutting-edge transplant research conducted by Professor Rogers and her team at The Westmead Institute for Medical Research (WIMR). Their work focuses on minimising rejection, improving transplant longevity, and reducing complications—all of which have been critical to Ray’s post-transplant recovery.

One of the key areas of research that influenced Ray’s care is transplant monitoring and immunosuppression management. After a kidney transplant, up to 20% of patients experience rejection, which can significantly shorten the life of the transplanted organ. The challenge is balancing immunosuppressive therapy—too little can lead to rejection, while too much increases the risk of life-threatening infections, cancer, and cardiovascular disease.

Ray’s post-transplant care was directly shaped by insights from Professor Rogers’ research into these risks. Her team is studying molecular markers that predict transplant rejection and investigating ways to fine-tune immunosuppression, ensuring that patients like Ray receive the most effective yet safest possible treatment.

A game-changing advancement: early rejection detection

Ray is particularly interested in an upcoming clinical trial that Professor Rogers’ team is preparing to launch—a trial that could transform transplant care worldwide. Currently, diagnosing rejection requires an invasive kidney biopsy, which carries risks such as bleeding and infection.

Professor Rogers’ team is developing a new blood test that would allow same-day detection of transplant rejection, making monitoring safer, faster, and more precise. When Ray saw a Channel 7 news segment featuring this research, he asked how he could be involved. Though the trial isn’t ready yet, with funding, it could begin by 2025—potentially benefiting thousands of transplant patients like Ray in the future.

A future transformed by research

For Ray, research isn’t just an abstract concept—it’s what gave him a second chance at life.

“Before all this, I thought research was just academic,” he says. “But now, I realise how much it improves lives. Without research, transplants and procedures like mine wouldn’t exist.”

For Professor Rogers, the impact goes beyond Ray’s case. The research being conducted at WIMR is shaping the future of transplant care, not only for kidney patients but also for heart and lung transplant recipients, where biopsy-based monitoring is even more challenging.

“Fifty years from now, the challenges I faced will likely be much easier for others,” Ray says. “Without research, progress in medicine would stall, and patients like me wouldn’t have the opportunities we do now.”

Ray’s successful transplant is proof of what’s possible when world-class care meets groundbreaking research. His journey highlights the critical role of research in transforming transplant care—not just for one patient, but for thousands more in the years to come.

Back